Prelude Capital Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-83,004
| Closed | -$1.26M | – | 1773 |
|
|
2022
Q3 | $1.26M | Buy |
+83,004
| New | +$1.26M | 0.05% | 342 |
|
|
2020
Q3 | – | Sell |
-14,786
| Closed | -$218K | – | 2007 |
|
|
2020
Q2 | $218K | Buy |
14,786
+3,880
| +36% | +$57.2K | 0.01% | 483 |
|
|
2020
Q1 | $147K | Sell |
10,906
-9,039
| -45% | -$122K | 0.01% | 291 |
|
|
2019
Q4 | $482K | Buy |
+19,945
| New | +$482K | 0.02% | 320 |
|
|
2019
Q3 | – | Sell |
-236
| Closed | -$7K | – | 1721 |
|
|
2019
Q2 | $7K | Sell |
236
-26,577
| -99% | -$788K | ﹤0.01% | 1084 |
|
|
2019
Q1 | $1.27M | Buy |
26,813
+12,661
| +89% | +$602K | 0.07% | 130 |
|
|
2018
Q4 | $511K | Sell |
14,152
-18,920
| -57% | -$683K | 0.03% | 291 |
|
|
2018
Q3 | $2.04M | Sell |
33,072
-6,246
| -16% | -$385K | 0.12% | 127 |
|
|
2018
Q2 | $2.66M | Sell |
39,318
-17,623
| -31% | -$1.19M | 0.17% | 79 |
|
|
2018
Q1 | $3.09M | Buy |
56,941
+24,974
| +78% | +$1.35M | 0.22% | 64 |
|
|
2017
Q4 | $1.91M | Buy |
31,967
+14,306
| +81% | +$855K | 0.15% | 114 |
|
|
2017
Q3 | $858K | Buy |
17,661
+2,858
| +19% | +$139K | 0.08% | 236 |
|
|
2017
Q2 | $778K | Sell |
14,803
-8,534
| -37% | -$449K | 0.07% | 223 |
|
|
2017
Q1 | $1.06M | Sell |
23,337
-7,352
| -24% | -$333K | 0.1% | 205 |
|
|
2016
Q4 | $1.16M | Sell |
30,689
-34,539
| -53% | -$1.31M | 0.14% | 172 |
|
|
2016
Q3 | $2.46M | Buy |
+65,228
| New | +$2.46M | 0.26% | 69 |
|
|
2015
Q2 | – | Sell |
-10,936
| Closed | -$343K | – | 2038 |
|
|
2015
Q1 | $343K | Buy |
+10,936
| New | +$343K | 0.05% | 447 |
|